Status: Not yet recruiting
Efficacy of CL25216 on Hormonal Balance and Menstrual Health in Women With Primary Dysmenorrhea.
This study is to evaluate the effects of CL25216 on hormonal balance and menstrual health in women with primary dysmenorrhea. Enrolled subjects will receive either CL25216 - 250 mg/day or placebo.
Participants needed: 80
Trial details
Age: 25-40Biological sex: FemaleType: InterventionalSponsor: ApexCPG LLCUpdated: Apr 14, 2026Locations: 1
Eligibility criteria
Healthy females aged between 25-40 years with a Body Mass Index (BMI) of approxi... [+11]
Subjects with irregular menstrual cycle (shorter than 21 and longer than 35 days... [+18]